UK consensus on normal tissue dose constraints for stereotactic radiotherapy
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...
Príomhchruthaitheoirí: | Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2017
|
Míreanna comhchosúla
Míreanna comhchosúla
-
UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
de réir: Hanna, G, et al.
Foilsithe / Cruthaithe: (2016) -
Stereotactic body radiotherapy for liver metastases.
de réir: Aitken, K, et al.
Foilsithe / Cruthaithe: (2015) -
Stereotactic body radiotherapy for oligometastases.
de réir: Tree, A, et al.
Foilsithe / Cruthaithe: (2013) -
A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
de réir: Khoo, V, et al.
Foilsithe / Cruthaithe: (2018) -
CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
de réir: Khoo, V, et al.
Foilsithe / Cruthaithe: (2017)